Supplementary Figures 1-7 from Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells Through Β1-Integrin Signaling

Tine S. Mantoni,Serena Lunardi,Osama Al-Assar,Atsushi Masamune,Thomas B. Brunner

DOI: https://doi.org/10.1158/0008-5472.22387205

2023-01-01

Abstract:Supplementary Figures 1-7 from Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through β1-Integrin Signaling

What problem does this paper attempt to address?

Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446371.v1

2023-01-01

Abstract:PDF file - 451K, Figure S5: CyPA promotes HAb18G/CD147-CD44s-pSTAT3 signaling and correlated pancreatic cell growth (related to Figure 2, 3). Figure S6: HAb18G/CD147 and CD44s are co-expressed and associated in pancreatic cancer (related to Figure 4).
Supplementary Figure 6 from Enhancement of Nab-Paclitaxel Antitumor Activity Through Addition of Multitargeting Antiangiogenic Agents in Experimental Pancreatic Cancer

Niranjan Awasthi,Changhua Zhang,Anna Schwarz,Stefan Hinz,Margaret A. Schwarz,Roderich E. Schwarz

DOI: https://doi.org/10.1158/1535-7163.22500697

2023-01-01

Abstract:PDF - 253K, Tumor tissue sections were stained with alpha-SMA antibody and slides were photographed under a fluorescent microscope. alpha-SMA pixel intensity was calculated and represented as bar graph. The data are expressed as the mean (plus or minus) standard deviation.
Supplementary Figures 1-3 from the Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer

Kun Guo,Jiujie Cui,Ming Quan,Dacheng Xie,Zhiliang Jia,Daoyan Wei,Liang Wang,Yong Gao,Qingyong Ma,Keping Xie

DOI: https://doi.org/10.1158/1078-0432.22462092.v1

2023-01-01

Abstract:Supplementary Figure S1. Expression of MSI2 in PDAC specimens. Supplementary Figure S2. Localization of MSI2 in PDAC cells. Supplementary Figure S3. Co-expression of MSI2 and KLF4 in colon and gastric cancer cells.
Supplementary Figure from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

Aislyn Schalck,Donastas Sakellariou-Thompson,Marie-Andrée Forget,Emi Sei,Tara G. Hughes,Alexandre Reuben,Shanshan Bai,Min Hu,Tapsi Kumar,Mark W. Hurd,Matthew H.G. Katz,Ching-Wei D. Tzeng,Shubham Pant,Milind Javle,David R. Fogelman,Anirban Maitra,Cara L. Haymaker,Michael P. Kim,Nicholas E. Navin,Chantale Bernatchez

DOI: https://doi.org/10.1158/2159-8290.22541809.v1

2023-01-01

Abstract:Supplementary Figure from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer
Figure S6 from ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer

Yun-Han Huang,Jing Hu,Fei Chen,Nicolas Lecomte,Harihar Basnet,Charles J. David,Matthew D. Witkin,Peter J. Allen,Steven D. Leach,Travis J. Hollmann,Christine A. Iacobuzio-Donahue,Joan Massagué

DOI: https://doi.org/10.1158/2159-8290.22535531.v1

2023-01-01

Abstract:Figure S6
Supplementary Figure.5 from the Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation

Xuebing Jia,Jianbei Xi,Binle Tian,Yuanyuan Zhang,Zhilong Wang,Fan Wang,Zheng Li,Jiang Long,JianFei Wang,Guo-Huang Fan,Qi Li

DOI: https://doi.org/10.1158/2326-6066.24935263

2024-01-01

Abstract:Effects of IPG1576 on the appearance of the spleen and the splenic immune cells.
SUPPLEMENTARY figure 6 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

Song Gao,Yan Sun,Xuebin Zhang,Limei Hu,Yuexin Liu,Corrine Yingxuan Chua,Lynette M. Phillips,He Ren,Jason B. Fleming,Huamin Wang,Paul J. Chiao,Jihui Hao,Wei Zhang

DOI: https://doi.org/10.1158/0008-5472.22412531.v1

2023-01-01

Abstract:Quantification of western blotting from main Figure 6 and the mRNA levels of PTEN.
Supplementary Figure 6 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Dongsheng Wang,Susan Müller,A.R.M. Ruhul Amin,Donghai Huang,Ling Su,Zhongliang Hu,Mohammad Aminur Rahman,Sreenivas Nannapaneni,Lydia Koenig,Zhengjia Chen,Mourad Tighiouart,Dong M. Shin,Zhuo G. Chen

DOI: https://doi.org/10.1158/1078-0432.22447170.v1

2023-01-01

Abstract:PDF file, 26K, Integrin β1 knock-down did not affected cell proliferation.
Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Li Lin,Brian Hutzen,Mingxin Zuo,Sarah Ball,Stephanie Deangelis,Elizabeth Foust,Bulbul Pandit,Michael A. Ihnat,Satyendra S. Shenoy,Samuel Kulp,Pui-Kai Li,Chenglong Li,James Fuchs,Jiayuh Lin

DOI: https://doi.org/10.1158/0008-5472.22387134.v1

2023-01-01

Abstract:Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Supplementary Figure 4 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446374

2023-01-01

Abstract:PDF file - 263K, The effects of HAb18G/CD147 promoting pancreatic tumor development are confirmed with pGIPZ and pTRIPZ CD147 shRNA (related to Figure 1).
Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Jun Zhao,Mark Z. Ma,Hening Ren,Zhenqiu Liu,Martin J. Edelman,Hong Pan,Li Mao

DOI: https://doi.org/10.1158/1078-0432.22452492.v1

2023-01-01

Abstract:Supplementary Figure 2 - PDF file 693K, Notch intracellular domain IHC
Pancreatic Stellate Cells And Pancreatic Cancer Cells: An Unholy Alliance

Alain Vonlaufen,Phoebe A Phillips,Zhihong Xu,David Goldstein,Romano C Pirola,Jeremy S Wilson,Minoti V Apte

DOI: https://doi.org/10.1158/0008-5472.CAN-08-1132

IF: 11.2

2008-01-01

Cancer Research

Abstract:Pancreatic cancer-a tumor displaying a particularly abundant stromal reaction-is notorious for its poor prognosis. Recent studies, via newly developed orthotopic models, provide compelling evidence of an important role for pancreatic stellate cells (PSC) in pancreatic cancer progression. Characterization of the mechanisms mediating PSC-cancer interactions will lead to the development of much needed alternative therapeutic approaches to improve disease outcome.
Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy

Zhengfeng Wang,Ru He,Shi Dong,Wence Zhou

DOI: https://doi.org/10.3389/fonc.2023.1185093

IF: 4.7

2023-06-20

Frontiers in Oncology

Abstract:Pancreatic cancer is a strongly malignant gastrointestinal carcinoma characterized by late detection, high mortality rates, poor patient prognosis and lack of effective treatments. Consequently, there is an urgent need to identify novel therapeutic strategies for this disease. Pancreatic stellate cells, which constitute a significant component of the mesenchymal cellular layer within the pancreatic tumor microenvironment, play a pivotal role in modulating this environment through their interactions with pancreatic cancer cells. This paper reviews the mechanisms by which pancreatic stellate cells inhibit antitumor immune responses and promote cancer progression. We also discuss preclinical studies focusing on these cells, with the goal of providing some theoretical references for the development of new therapeutic approaches for pancreatic cancer.

oncology
Supplementary Figure 1 from Interaction of the Sympathetic Nerve with Pancreatic Cancer Cells Promotes Perineural Invasion Through the Activation of STAT3 Signaling

Kun Guo,Qingyong Ma,Junhui Li,Zheng Wang,Tao Shan,Wei Li,Qinhong Xu,Keping Xie

DOI: https://doi.org/10.1158/1535-7163.22498245

2023-01-01

Abstract:PDF file, 45KB, Effects of beta-AR antagonists on PNI
SUPPLEMENTARY figure 5 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

Song Gao,Yan Sun,Xuebin Zhang,Limei Hu,Yuexin Liu,Corrine Yingxuan Chua,Lynette M. Phillips,He Ren,Jason B. Fleming,Huamin Wang,Paul J. Chiao,Jihui Hao,Wei Zhang

DOI: https://doi.org/10.1158/0008-5472.22412534

2023-01-01

Abstract:Quantification of western blotting from main Figure 5.
Supplementary Figure 5 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Li Lin,Brian Hutzen,Mingxin Zuo,Sarah Ball,Stephanie Deangelis,Elizabeth Foust,Bulbul Pandit,Michael A. Ihnat,Satyendra S. Shenoy,Samuel Kulp,Pui-Kai Li,Chenglong Li,James Fuchs,Jiayuh Lin

DOI: https://doi.org/10.1158/0008-5472.22387140.v1

2023-01-01

Abstract:Supplementary Figure 5 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Figure S2 from ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer

Yun-Han Huang,Jing Hu,Fei Chen,Nicolas Lecomte,Harihar Basnet,Charles J. David,Matthew D. Witkin,Peter J. Allen,Steven D. Leach,Travis J. Hollmann,Christine A. Iacobuzio-Donahue,Joan Massagué

DOI: https://doi.org/10.1158/2159-8290.22535543.v1

2023-01-01

Abstract:Figure S2
Supplementary Figure 2 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Dongsheng Wang,Susan Müller,A.R.M. Ruhul Amin,Donghai Huang,Ling Su,Zhongliang Hu,Mohammad Aminur Rahman,Sreenivas Nannapaneni,Lydia Koenig,Zhengjia Chen,Mourad Tighiouart,Dong M. Shin,Zhuo G. Chen

DOI: https://doi.org/10.1158/1078-0432.22447182

2023-01-01

Abstract:PDF file, 359K, OS and DFS analysis of chemotherapy on all patients.
SUPPLEMENTARY figure 7 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

Song Gao,Yan Sun,Xuebin Zhang,Limei Hu,Yuexin Liu,Corrine Yingxuan Chua,Lynette M. Phillips,He Ren,Jason B. Fleming,Huamin Wang,Paul J. Chiao,Jihui Hao,Wei Zhang

DOI: https://doi.org/10.1158/0008-5472.22412528

2023-01-01

Abstract:<p>Expression of IGFBP1, IGFBP3, IGFBP4, and IGFBP5 in tumors from PDAC patients and relationship of IGFBP3 and IGFBP5 expression to patient survival.</p>
Supplementary Figure 6 from Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma

Dan Huang,Yan Ding,Ming Zhou,Brian I. Rini,David Petillo,Chao-Nan Qian,Richard Kahnoski,P. Andrew Futreal,Kyle A. Furge,Bin Tean Teh

DOI: https://doi.org/10.1158/0008-5472.22387296.v1

2023-01-01

Abstract:Supplementary Figure 6 from Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma

Supplementary Figures 1-7 from Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells Through Β1-Integrin Signaling

Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Supplementary Figure 6 from Enhancement of Nab-Paclitaxel Antitumor Activity Through Addition of Multitargeting Antiangiogenic Agents in Experimental Pancreatic Cancer

Supplementary Figures 1-3 from the Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer

Supplementary Figure from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

Figure S6 from ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer

Supplementary Figure.5 from the Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation

SUPPLEMENTARY figure 6 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

Supplementary Figure 6 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Supplementary Figure 4 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Pancreatic Stellate Cells And Pancreatic Cancer Cells: An Unholy Alliance

Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy

Supplementary Figure 1 from Interaction of the Sympathetic Nerve with Pancreatic Cancer Cells Promotes Perineural Invasion Through the Activation of STAT3 Signaling

SUPPLEMENTARY figure 5 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

Supplementary Figure 5 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Figure S2 from ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer

Supplementary Figure 2 from the Pivotal Role of Integrin Β1 in Metastasis of Head and Neck Squamous Cell Carcinoma

SUPPLEMENTARY figure 7 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

Supplementary Figure 6 from Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma